23-Oct-2026 08:26:22
SUNPHARMAGeneral news
SUN PHARMA: RAISES ₹7,816 CR THROUGH BONDS; FALLS SHORT OF ₹10,000 CR TARGET ; ET REPORT 🔴🔴
• Fundraising: Raised ₹7,816 Cr through bond issuance against planned ₹10,000 Cr • 5-Year Bonds: Priced at 8.05% annual coupon rate • 7-Year Bonds: Priced at 8.20% annual coupon rate • Anchor Investment: Secured ₹2,100 Cr through anchor investors • Fundraising Shortfall: Raised ₹2,184 Cr less than targeted amid rising bond yields and cautious investor sentiment • Borrowing Costs: Bond issuance adds interest obligations, potentially increasing finance costs Impact: Mixed (Successful ₹7,816 Cr fundraising strengthens liquidity, but the shortfall against the target and relatively high borrowing costs remain concerns.)
SUN PHARMACEUTICAL IND L